Vertex Pharmaceuticals

AI Score

0
XX

Unlock

411.00
-2.37 (-0.57%)
At close: Jan 14, 2025, 3:59 PM
412.89
0.46%
After-hours Jan 14, 2025, 06:30 PM EST

Vertex Pharmaceuticals Revenue Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Sep 30, 2020Jun 30, 2020Mar 31, 2020
TRIKAFTA/KAFTRIO Revenue 2.58B 2.45B 2.48B 2.33B 2.27B 2.24B 2.10B 2.02B 2.01B 1.89B 1.76B 1.69B 1.56B 1.26B 1.19B 960.31M 917.72M 895.23M
TRIKAFTA/KAFTRIO Revenue Growth +5.54% -1.39% +6.44% +2.59% +1.51% +6.85% +3.72% +0.55% +6.20% +7.47% +4.08% +8.79% +23.91% +5.23% +24.25% +4.64% +2.51% n/a

Revenue by Geography

Quarter Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017Dec 31, 2016Dec 31, 2015Dec 31, 2014Dec 31, 2013Dec 31, 2012Dec 31, 2011
Europe Revenue 3.11B 2.71B 1.97B 1.13B 885.76M 543.18M 420.32M 320.46M 219.60M 197.61M 279.56M 1.37B 1.39B
Europe Revenue Growth +14.91% +37.13% +75.14% +27.17% +63.07% +29.23% +31.16% +45.93% +11.13% -29.31% -79.65% -1.16% n/a
Non-Us Revenue 4.55B 3.76B 2.60B 1.63B 1.31B 821.86M 501.87M 380.37M 269.02M 219.34M 315.02M n/a n/a
Non-Us Revenue Growth +21.06% +44.55% +59.82% +23.70% +59.98% +63.76% +31.94% +41.39% +22.65% -30.37% n/a n/a n/a
United States Revenue 6.04B 5.70B 5.29B 4.83B 3.06B 2.37B 1.99B 1.32B 763.32M 361.07M 896.95M n/a n/a
United States Revenue Growth +5.98% +7.79% +9.48% +57.69% +29.49% +19.04% +50.31% +73.17% +111.40% -59.74% n/a n/a n/a

Operating Expense Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016Jun 30, 2016Mar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
Selling, General, and Administrative Revenue 371.80M 372.20M 342.70M 369.10M 263.80M 262.60M 241.10M 267.40M 246.80M 215.30M 215.20M 255.20M 198.19M 194.67M 192.08M 211.84M 184.55M 191.80M 182.26M 195.28M 159.67M 156.50M 147.04M 153.21M 137.29M 137.30M 129.81M 134.79M 120.71M 127.25M 113.33M 109.91M 106.06M 111.65M 105.21M 97.05M 99.77M 94.39M 85.86M
Selling, General, and Administrative Revenue Growth -0.11% +8.61% -7.15% +39.92% +0.46% +8.92% -9.84% +8.35% +14.63% +0.05% -15.67% +28.77% +1.81% +1.35% -9.33% +14.79% -3.78% +5.24% -6.67% +22.30% +2.03% +6.43% -4.02% +11.59% -0.01% +5.77% -3.70% +11.67% -5.14% +12.29% +3.11% +3.63% -5.01% +6.12% +8.41% -2.72% +5.70% +9.94% n/a
Research and Development Revenue 875.90M 5.42B 865.90M 821.80M 810.00M 785.70M 742.60M 694.10M 645.00M 600.10M 603.10M 694.30M 493.75M 1.41B 455.97M 466.58M 493.50M 420.93M 448.53M 480.01M 555.95M 379.09M 339.49M 437.88M 330.51M 337.53M 310.55M 306.66M 454.95M 289.45M 273.56M 248.45M 275.37M 271.01M 255.86M 310.43M 246.28M 223.86M 215.60M
Research and Development Revenue Growth -83.83% +525.44% +5.37% +1.46% +3.09% +5.80% +6.99% +7.61% +7.48% -0.50% -13.14% +40.62% -64.91% +208.59% -2.27% -5.45% +17.24% -6.15% -6.56% -13.66% +46.65% +11.66% -22.47% +32.49% -2.08% +8.69% +1.27% -32.59% +57.18% +5.81% +10.11% -9.78% +1.61% +5.92% -17.58% +26.05% +10.02% +3.83% n/a

Create Price Alert on VRTX

Your price alert will notify you when the stock price is above 411.00.

Add to Watchlist